drugset / Trial / NCT01083797

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

NCT01083797

NaSingle-groupSingle-blindTreatment

Summary

This study evaluates the use of dexmedetomidine or chloral hydrate for sedation during electroencephalography in patients with neurological disorders. The hypothesis is that this drugs provides similar changes in EEG pattern.

Timeline

Start
2009-12
Primary completion
2013-03
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloral Hydrate Small molecule 50 mg/kg
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg

Indications